MELF pattern invasion in endometrial carcinoma: Association with low grade, myoinvasive endometrioid tumours, focal mucinous differentiation and vascular invasion

Pathology

Volumn 41, Issue 5, 2009, Pages 454-459

  Stewart, C J R ^a   Brennan, B A ^a   Leung, Y C ^b   Little, L ^a  

^a KING EDWARD MEMORIAL HOSPITAL   (Australia)

^b UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

Carcinoma; Endometrium; Immunohistochemistry; Invasion; MELF

Indexed keywords

CYTOKERATIN; MUCIN;

AGED; ARTICLE; CANCER DIAGNOSIS; CANCER INVASION; CONTROLLED STUDY; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; DISEASE SEVERITY; ENDOMETRIUM CARCINOMA; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH VESSEL; MAJOR CLINICAL STUDY; MUCINOUS CARCINOMA; SQUAMOUS CELL CARCINOMA; VASCULAR ENDOTHELIUM;

EID: 68049126022     PISSN: 00313025     EISSN: 14653931     Source Type: Journal    
DOI: 10.1080/00313020903041135     Document Type: Article

References (34)

1. Australian Institute of Health and Welfare (AIHW). Cancer in Australia: An Overview, 2006. Canberra: AIHW, 2007.
2. Amant F, Moerman P, Timmerman D, Van Limbergen E, Vergote I. Endometrial cancer. Lancet 2005; 366: 491-505.
3. Sorosky JI. Endometrial cancer. Obstet Gynecol 2008; 111: 436-447
4. Prat J. Prognostic parameters of endometrial carcinoma. Hum Pathol 2004; 35: 649-662
5. Moberger B, Auer G, Einhorn N, Moberger G. The prognostic significance of growth pattern and its relation to tumor cell nuclear DNAcontent in endometrial carcinoma. ActaOncologica 1990; 29: 17-23.
6. Lee KR, Vacek PM, Belinson JL. Traditional and nontraditional histopathologic predictors of recurrence in uterine endometrioid adenocarcinoma. Gynecol Oncol 1994; 54: 10-18.
7. Stefansson IM, Salvesen HB, Immervoll H, Akslen LA. Prognostic impact of histological grade and vascular invasion compared with tumour cell proliferation in endometrial carcinoma of endometrioid type. Histopathology 2004; 4: 472-479
8. Suzuki C, Matsumoto T, Sonoue H, Arakawa A, Furugen Y, Kinoshita K. Prognostic significance of the infiltrative pattern invasion in endometrioid adenocarcinoma of the endometrium. Pathol Int 2003; 53: 495-500.
9. Burton JL, Wells M. Recent advances in the histopathology and molecular pathology of carcinoma of the endometrium. Histopathology 1998; 33: 297-303.
10. Alkushi A, Lim P, Coldman A, Huntsman D, Miller D, Gilks CB. Interpretation of p53 immunoreactivity in endometrial carcinoma: establishing a clinically relevant cut-off level. Int J Gynecol Pathol 2004; 23: 129-137
11. Cerezo L, Cardenes H, Michael H. Molecular alterations in the pathogenesis of endometrial adenocarcinoma. Therapeutic implications. Clin Transl Oncol 2006; 8: 231-241
12. Salvesen HB, Akslen LA. Molecular pathogenesis and prognostic factors in endometrial carcinoma. APMIS 2002; 110: 673-689
13. Ali A, Black D, Soslow RA. Diffculties in assessing the depth of myometrial invasion in endometrial carcinoma. Int J Gynecol Pathol 2007; 26: 115-123
14. Mittal KR, Barwick KW. Diffusely infiltrating adenocarcinoma of the endometrium.Asubtype with poor prognosis. AmJ Surg Pathol 1998; 12: 754-758
15. Landry D, Mai KT, Senterman MK, et al. Endometrioid adenocarcinoma of the uterus with a minimal deviation invasive pattern. Histopathology 2003; 42: 77-82.
16. Longacre T, Hendrickson MR. Diffusely infiltrative endometrial adenocarcinoma: an adenoma malignum pattern of myoinvasion. Am J Surg Pathol 1999; 23: 69-78.
17. Clement PB, Young RH. Atlas of Gynecologic Surgical Pathology. 2nd ed. Philadelphia: Elsevier Saunders, 2008; 161-193
18. Crum CP, Duska L, Lee KR, Mutter GL. Adenocarcinoma, carcinosarcoma and other epithelial tumors of the endometrium. In: Crum CP, Lee KR, editors. Diagnostic Gyencologic and Obstetric Pathology. Philadelphia: Elsevier Saunders, 2006; 545-610.
19. Ambros RA, Ballouk F, Malfetano JH, Ross JS. Significance of papillary (villoglandular) differentiation in endometrioid carcinoma of the uterus. Am J Surg Pathol 1994; 18: 569-575
20. Murray SK, Young RH, Scully RE. Unusual epithelial and stromal changes in myoinvasive endometrioid adenocarcinomas: a study of their frequency, associated diagnostic problems, and prognostic significance. Int J Gynecol Pathol 2003; 22: 324-333
21. Shia J, Black D, Hummer AJ, Boyd J, Soslow RA. Routinely assessed morphological features correlate with microsatellite instability status in endometrial cancer. Hum Pathol 2008; 39: 116-125
22. Silva EG, Deavers MT, Bodurka DC, Malpica A. Association of lowgrade endometrioid carcinoma of the uterus and ovary with unDifferentiated carcinoma: a new type of Dedifferentiated carcinoma? Int J Gynecol Pathol 2006; 25: 52-58
23. Nucci MR, Prasad CJ, Crum CP, Mutter GL. Mucinous endometrial epithelial proliferations: a morphologic spectrum of changes with diverse clinical significance. Mod Pathol 1999; 12: 1137-1142
24. Clement PB, Young RH. Endometrioid carcinoma of the uterine corpus: a review of its pathology with emphasis on recent advances and problematic aspects. Adv Anat Pathol 2002; 9: 145-184
25. Saegusa M, Okayasu I. Frequent nuclear beta-catenin accumulation and associated mutations in endometrioid-type endometrial and ovarian carcinomas with squamous differentiation. J Pathol 2001; 194: 59-67.
26. Ashihara K, Saito T, Mizumoto H, et al. Loss of gamma-Catenin expression in squamous differentiation in endometrial carcinomas. Int J Gynecol Pathol 2002; 21: 246-254
27. Wani Y, Notohara K, Saegusa M, Tsukayama C. Aberrant Cdx2 expression in endometrial lesions with squamous differentiation: important role of Cdx2 in squamous morula formation. Hum Pathol 2008; 39: 1072-1079
28. Peiro G, Diebold J, Lohse P, et al. Microsatellite instability, loss of heterozygosity, and loss of hMLH1 and hMSH2 protein expression in endometrial carcinoma. Hum Pathol 2002; 33: 347-354
29. Honore LH, Hanson J, Andrew SE, Microsatellite instability in endometrioid endometrial carcinoma: correlation with clinically relevant pathologic variables. Int J Gynecol Pathol 2006; 16: 386-392
30. Nofech-Mozes S, Ghorab Z, Ismiil N, et al. Endometrial endometrioid adenocarcinoma. A pathologic analysis of 827 consecutive cases. Am J Clin Pathol 2008; 129: 110-114
31. Inoue Y, Obata K, Abe K, et al. The prognostic significance of vascular invasion by endometrial carcinoma. Cancer 1996; 78: 1447-1451
32. Zaino RJ. Lymph-vascular space invasion in endometrial adenocarcinoma: confusion, confessions, and conclusions. Gynecol Oncol 2002; 87: 240-242
33. Littlepage LE, Egeblad M, Werb Z. Coevolution of cancer and stromal cellular responses. Cancer Cell 2005; 7: 499-500.
34. Stern R. Association between cancer and "acid mucopolysaccharides": an old concept comes of age, .nally. Semin Cancer Biol 2008; 18: 238-243